Session 7: Pharmacogenomics

This course will give participants a broad perspective on the emergence of clinical and applied pharmacogenomics (PGx) and provide them with insight into its growing importance in major clinical therapeutic areas.
 
 

Target Audience

  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Pharmacists
  • Genetic Counselors
  • Other clinicians

Learning Objectives

Participants who engage in this education intervention will be able to:

1. Summarize the fundamentals of pharmacogenomics as a foundation for clinical implementation.
2. Examine how pharmacogenomics connects to other aspects of clinical pharmacology.
3. Hypothesize strategies and examples for developing a pharmacogenomics implementation program.
Additional information
AttachmentSize
File PM ED CME_Graduate Program Slides_2023.pptx5.01 MB
PDF icon PGx Reading 1_Roden et al 2019.pdf373.56 KB
PDF icon PGx Reading 2_Chenoweth et al 2020.pdf120.4 KB
PDF icon PGx Reading 3_Haidar et al 2022.pdf1007 KB

Contact

Name: 
Kellie LeGrave
Phone Number: 
+1 (414) 955-4139
Email: 
klegrave@mcw.edu
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.50 Genetic Counselor CEU
  • 1.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
03/14/2024
Course expires: 
07/12/2024
Cost:
$0.00
Part of: 
Precision Medicine Continuing Education Program Spring 2024
This module is presented with a pre-recorded PowerPoint presentation and sound.  An audio lecture is given using visual key points listed on the PowerPoint presentation.  Following the presentation, learners will be asked quiz questions to test retainment of knowledged gained in the presentation. Learners are able to complete the module at their own pace.
Bradley Stockard, PharmD, PhD joined the MCW School of Pharmacy in August 2022. He received his PharmD from the University of Missouri – Kansas City School of Pharmacy and PhD in Pharmaceutical Sciences from the University of Florida. He is a graduate of the Clinical Pharmacology T32 Fellowship program which he completed at Children’s Mercy Hospital in Kansas City, MO. He served as Chief Fellow from 2021-2022. During his fellowship, he completed a research rotation with the Center for Drug Evaluation and Research department at the FDA. His research interests are in multi-omics association studies on variations in treatment outcomes for pediatric leukemias and neonatology. He has presented his research at American Society of Hematology and American Society of Clinical Pharmacology and Therapeutic Annual Conferences.

 

Activity Director
John Meurer, MD, MBA
 
 
Planning Committee:
John Meurer, MD, MBA
Institute Director, Professor
Administration, Institute for Health & Equity

 

Bradley Stockard, PharmD
Assistant Professor
Administration, School of Pharmacy Administration

 

Jennifer Geurts, MS, CGC
Director, Assistant Professor
Administration, Institute for Health and Equity

 

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

 

  • Bradley Stockard
  • Donald Basel
  • Gwen Lomberk
  • Jake Luo
  • Jennifer Geurts
  • Jeremy Garrett
  • John Meurer
  • Michael Zimmerman

The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

 

Name
Company
Role
Honey Reddi, PhD
Belay Diagnostics
Biofidelity, Inc.
Employee
Consultant
Ben George, MD
Ipsen, Foundation Medicine,
Taiho Oncology
Consultant

 

Available Credit

  • 1.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.50 Genetic Counselor CEU
  • 1.50 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.